Should furosemide (Lasix) be held in a hospitalized patient with hepatic encephalopathy who has hypotension and bradycardia (55–60 bpm)?

Yes, Hold Lasix in This Patient

In a hospitalized patient with hepatic encephalopathy who has hypotension ("soft BP") and bradycardia (55-60 bpm), furosemide (Lasix) should be discontinued immediately. This clinical scenario presents multiple contraindications to continued diuretic therapy that take precedence over fluid management.

Primary Rationale for Holding Diuretics

Hepatic Encephalopathy as a Contraindication

Diuretics are generally contraindicated in patients with overt hepatic encephalopathy 1. The EASL guidelines explicitly state that "diuretics are generally contraindicated in patients with overt hepatic encephalopathy" 1. The Korean guidelines similarly recommend that "in cases of hepatic encephalopathy...diuretics should be stopped and the patient's status should be reevaluated" 2.

The mechanism is clear: diuretics can precipitate or worsen hepatic encephalopathy through multiple pathways:

• Electrolyte disturbances (particularly hypokalemia)
• Volume depletion leading to azotemia
• Worsening of circulatory dysfunction

Hypotension as an Additional Contraindication

The presence of hypotension compounds the problem. The FDA label for furosemide warns that "excessive diuresis may cause dehydration and blood volume reduction with circulatory collapse" 3. In cirrhotic patients specifically, the FDA states: "In patients with hepatic cirrhosis and ascites, furosemide therapy is best initiated in the hospital. In hepatic coma and in states of electrolyte depletion, therapy should not be instituted until the basic condition is improved. Sudden alterations of fluid and electrolyte balance in patients with cirrhosis may precipitate hepatic coma" 3.

Hypotension in cirrhosis with hepatic encephalopathy is particularly dangerous because it can lead to:

• Impaired cerebral perfusion, potentially worsening encephalopathy 4
• Acute kidney injury, which further exacerbates hyperammonemia
• Circulatory collapse in an already hyperdynamic circulatory state

Bradycardia Consideration

While bradycardia (55-60 bpm) is relatively mild, it signals potential hemodynamic instability. The combination of bradycardia with hypotension suggests inadequate compensatory mechanisms and increased risk of cardiovascular decompensation.

Specific Management Algorithm

Step 1: Immediate Actions

• Discontinue furosemide immediately 1
• Discontinue spironolactone or other aldosterone antagonists as well
• Hold any non-selective beta-blockers if the patient is on them for portal hypertension 5

Step 2: Assess Volume Status

• Evaluate for signs of hypovolemia (orthostatic changes, decreased urine output, elevated BUN/creatinine ratio)
• Check for signs of dehydration versus true hypotension from circulatory dysfunction
• The Canadian guidelines note that "a common cause [of increasing creatinine] is hypovolemia. A volume assessment of the patient is warranted and reduction/temporary cessation of diuretics" 6

Step 3: Laboratory Monitoring

• Check serum electrolytes (sodium, potassium, chloride)
• Measure serum creatinine and BUN
• Assess ammonia level if not recently done
• Correct hypokalemia if present, as this can worsen encephalopathy 1

Step 4: Treat Hepatic Encephalopathy

• Initiate or optimize lactulose therapy
• Consider rifaximin if not already prescribed
• Search for precipitating factors: infection (perform diagnostic paracentesis), GI bleeding, constipation, medications 2, 7

Step 5: Address Hypotension

• If hypovolemic: cautious fluid resuscitation with albumin or balanced crystalloids 8
• If not hypovolemic: evaluate for sepsis, bleeding, or cardiac dysfunction
• Avoid aggressive fluid resuscitation if patient has significant ascites without true hypovolemia

Step 6: When to Restart Diuretics

• Do not restart diuretics until:
  • Hepatic encephalopathy has resolved or significantly improved 1
  • Blood pressure has stabilized (systolic >90 mmHg consistently)
  • Electrolytes are corrected
  • Renal function is stable or improving
  • Any precipitating factors have been addressed

Critical Pitfalls to Avoid

1. Do not continue diuretics "because the patient has ascites" - The presence of ascites does not override the contraindication of overt hepatic encephalopathy 1

2. Do not assume hypotension is solely from diuretics - Evaluate for sepsis, spontaneous bacterial peritonitis, GI bleeding, or cardiac dysfunction 8

3. Do not restart diuretics too early - The EASL guidelines emphasize that diuretics should be discontinued if there is "worsening hepatic encephalopathy" and only restarted when the condition improves 1

4. Do not forget to check for precipitating factors - Hepatic encephalopathy rarely occurs in isolation; infection, bleeding, constipation, or medications are often triggers 2, 7

5. Avoid rapid correction of hyponatremia if present - This can lead to osmotic demyelination syndrome 9

Special Considerations

The 2018 EASL guidelines note that "diuretic therapy is generally not recommended in patients with persistent overt hepatic encephalopathy" 7. This is a stronger statement than simply holding during an acute episode - it suggests that patients with recurrent or persistent encephalopathy may need alternative strategies for ascites management, such as serial large-volume paracentesis with albumin replacement.

Research evidence supports this cautious approach: one study found that furosemide, particularly at doses ≥20 mg/day, was associated with unfavorable outcomes in patients with hepatic encephalopathy receiving rifaximin, including increased occurrence and recurrence of overt encephalopathy 10.

In summary: The combination of hepatic encephalopathy, hypotension, and bradycardia represents a clear indication to discontinue furosemide. The patient's hemodynamic instability and altered mental status must be stabilized before any consideration of restarting diuretics.